CAS Medical Systems, Inc. (NASDAQ:CASM) posted its quarterly earnings results on Tuesday. The medical technology company reported ($0.09) EPS for the quarter, missing the consensus estimate of ($0.07) by $0.02, MarketWatch Earnings reports. The business had revenue of $4.57 million for the quarter, compared to analysts’ expectations of $5.41 million.

CAS Medical Systems (NASDAQ CASM) remained flat at $0.99 on Wednesday. The company had a trading volume of 65,167 shares. CAS Medical Systems has a one year low of $0.80 and a one year high of $1.94. The firm’s market cap is $27.06 million. The company has a 50 day moving average price of $1.15 and a 200 day moving average price of $1.28.

ILLEGAL ACTIVITY NOTICE: This article was originally posted by Daily Political and is owned by of Daily Political. If you are viewing this article on another site, it was illegally copied and republished in violation of U.S. & international copyright and trademark legislation. The correct version of this article can be viewed at

CAS Medical Systems Company Profile

CAS Medical Systems, Inc is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products for patient care. The Company designs, manufactures and distributes the FORE-SIGHT and FORE-SIGHT ELITE brand tissue oximeters and sensors. It operates through Tissue Oximetry Monitoring, which includes sales of its FORE-SIGHT tissue oximeter monitors, sensors and accessories.

Earnings History for CAS Medical Systems (NASDAQ:CASM)

Receive News & Ratings for CAS Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CAS Medical Systems Inc. and related companies with's FREE daily email newsletter.